Physician profile
Micah A Berman
NPI 1972747871
$1,043.07
in general payments reported to CMS, 2019-2025
14 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.66 · 2020: $111 · 2021: $18.99 · 2022: $58.47 · 2023: $581 · 2024: $36.73 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $471 · Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $470.90 |
| Food and Beverage | $371.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $612.29 | 2019-2025 | Coblation, Tula |
| Glaxosmithkline, LLC. | $85.29 | 2022-2025 | Nucala |
| Aerin Medical INC. | $70.11 | 2020-2025 | |
| Intersect Ent, INC. | $67.25 | 2020 | |
| Stryker Corporation | $44.11 | 2021-2025 | Scopis Ent |
| Merck Sharp & Dohme LLC | $35.37 | 2023-2025 | Keytruda |
| Hologic Sales and Service, LLC | $29.47 | 2025 | Coolseal Generator |
| Acera Surgical, INC. | $17.46 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $15.42 | 2025 | Propel |
| Phadia US INC. | $14.14 | 2025 | Immunocap |
| Integra Lifesciences Corporation | $14.01 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Cochlear Americas | $13.54 | 2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Genzyme Corporation | $12.70 | 2022 | |
| Optinose US, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.